PPA
BNTX icon

Parametric Portfolio Associates’s BioNTech BNTX Stock Holding History

Parametric Portfolio Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$711K Buy
4,169
+2,274
+120% +$382K ﹤0.01% 2938
2021
Q4 		$489K Buy
1,895
+709
+60% +$194K ﹤0.01% 3077
2021
Q3 		$324K Buy
+1,186
New +$377K ﹤0.01% 3269

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Parametric Portfolio Associates's BNTX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its BioNTech (BNTX) stake by 120% in Q1 2022, buying an estimated $382K and bringing the position to 4,169 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

Parametric Portfolio Associates first reported a position in BNTX in Q3 2021 and has held it in 3 quarters since. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Parametric Portfolio Associates held 4,169 shares of BioNTech worth $711K as of Q1 2022.
  • Parametric Portfolio Associates bought 2,274 BioNTech shares in Q1 2022, an estimated $382K.
  • BioNTech made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2938 holding.
  • Parametric Portfolio Associates first reported a position in BioNTech in Q3 2021 and has held it in 3 quarters since.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.